SUMACTA 100mg tablets medication leaflet

N02CC01 sumatriptan • Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists

Sumatriptan is a 5-HT1 receptor agonist used for the treatment of acute migraine and cluster headaches. It works by constricting blood vessels in the brain and reducing inflammation associated with migraines.

The medication is available in the form of tablets, injections, or nasal spray and should be taken as directed by a doctor, usually at the onset of migraine symptoms.

Patients should be aware of potential side effects, such as dizziness, nausea, or a sensation of pressure in the chest. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, nausea, fatigue, and tingling sensations. In rare cases, severe reactions such as high blood pressure or myocardial ischemia may occur. Patients should be informed of these risks before starting treatment.

General data about SUMACTA 100mg

Substance: sumatriptan

Date of last drug list: 01-06-2025

Commercial code: W59112004

Concentration: 100mg

Pharmaceutical form: tablets

Quantity: 6

Product type: generic

Price: 58.34 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ACTAVIS HF - ISLANDA

Holder: ACTAVIS GROUP PTC EHF. - ISLANDA

Number: 4993/2012/04

Shelf life: 3 years

Pharmaceutical forms available for sumatriptan

Concentrations available for sumatriptan

100mg, 3mg/0.5ml, 50mg

Compensation lists for SUMACTA 100mg ACTAVIS

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

58.34 RON

52.51 RON

5.83 RON